These ΔEx50-Dmd-Luc mice represent a valuable model for optimizing the genetic correction of DMD using CRISPR/Cas9, as well as for studying the impact of other correction strategies and pharmacologic interventions on progression of the disease. Here, DMD is linked to Duchenne muscular dystrophy.